1.7 semaglutide to tirzepatide vs. for Weight Loss Cardiovascular outcomes of semaglutide and

Madison Medispa in Waunakee, WI

In the trial that got Zepbound approved, the average person on the highest 15 mg dose lost 20.9% of their body weight over 72 weeks

Treatment-effect on eGFR slopes was assessed by fitting a linear regression model per patient, followed by a t-test to compare the slopes between the groups

We explore safety, cost, and efficacy to identify the best testosterone-boosting supplement for women.

Mechanistically, these effects are linked to GLP-1 RA-mediated suppression of inflammatory pathways, modulation of skeletal muscle metabolism, and preservation of mitochondrial function, thereby influencing insulin resistance

How Does It Work